CN Patent

CN107412229A — 毒蕈碱受体拮抗剂和β‑2肾上腺素受体激动剂的组合

Assigned to Glaxo Group Ltd · Expires 2017-12-01 · 8y expired

What this patent protects

提供了用于经由鼻或口吸入给药的毒蕈碱乙酰胆碱受体拮抗剂与β‑2激动剂的新组合，以及使用所述组合的方法。

USPTO Abstract

提供了用于经由鼻或口吸入给药的毒蕈碱乙酰胆碱受体拮抗剂与β‑2激动剂的新组合，以及使用所述组合的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN107412229A
Jurisdiction
CN
Classification
—
Expires
2017-12-01
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.